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Background
Alzheimer’s disease (AD) is an age-related, progressive
neurodegenerative disorder that occurs gradually and
results in memory, behavior and personality change.
Geniposide, an iridoid glycosides isolated from the Tra-
ditional Chinese Medicine Gardenia jasminoides. Ellis,
has been demonstrated to have neuroprotective effects.
Method
The present report primarily studied the effects of genipo-
side on cognitive dysfunction in a double-transgenic AD
mouse model (APP/PS1) on early and late stages. Male
APP/PS1 mice aged 6 month and 12 month were given
water, geniposide (25mg.kg
-1)o n c ead a yb yo r a lg a v a g e ,
and age-matched C57BL/6 mice were treated with water
and geniposide (25mg.kg
-1). Aricept (0.75mg.kg
-1)w a s
used in the positive control group. Morris water maze per-
formance was assessed after 3 months of treatment.
Result
The APP/PS1 mice had longer escape latency and lower
percentage of activities in platform quadrant than the
C57BL/6 mice (p<0.05) both in the early- and late-stage
treatment. In addition, geniposide significantly improved
learning deficits as well as Aricept, compared with vehi-
cle control treatment (p<0.05).
Conclusion
Geniposide can improve cognitive function of the dou-
ble transgenic mouse model at early and late-stage of
Alzheimer’s disease, with a possible mechanism related
with neuroprotective and anti-inflammatory activities.
The study suggested that oral supplementation of geni-
poside might be a potential therapeutic strategy for the
treatment of early- and late-stage of Alzheimer’s disease.
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